Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats

European Journal of Pharmacology

Volumn 586, Issue 1-3, 2008, Pages 52-58

  Mori, Nobuhiro ^a   Yokooji, Tomoharu ^a   Kamio, Yoshihiro ^b   Murakami, Teruo ^a  

^a HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

Absorption; Bile; CNT1; CNT2; Concentrative nucleoside transporter; Intestine; Mizoribine

Indexed keywords

ADENOSINE; BILE SALT; CHOLIC ACID; GEMCITABINE; GLYCOCHOLATE SODIUM; INOSINE; MIZORIBINE; NUCLEOSIDE ANALOG; NUCLEOSIDE TRANSPORTER; PURINE NUCLEOSIDE DERIVATIVE; RIBAVIRIN; THYMIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; ELECTRICITY; INTESTINE ABSORPTION; MALE; MICELLE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ANIMALS; ANTIMETABOLITES; BILE ACIDS AND SALTS; BIOLOGICAL AVAILABILITY; CARRIER PROTEINS; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INTESTINAL ABSORPTION; MALE; MEMBRANE TRANSPORT PROTEINS; NUCLEOSIDES; RATS; RATS, SPRAGUE-DAWLEY; RIBAVIRIN; RIBONUCLEOSIDES;

EID: 43549095467     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.043     Document Type: Article

References (29)

1. Abe Y., Tsuji Y., Hisano M., Nakada M., Miura K., Watanabe S., Odajima Y., and Iikura Y. Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis. Pediatr. Int. 46 (2004) 597-600
2. Alrefai W.A., and Gill R.K. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res. Apr 3 (2007) [Electronic publication ahead of print]
3. Baldwin S.A., Mackey J.R., Cass C.E., and Young J.D. Nucleoside transporters: molecular biology and implication for therapeutic development. Mol. Med. Today. 5 (1999) 216-224
4. Casado F.J., Lostao M.P., Aymerch I., Larrayoz I.M., Duflot S., Mulero R., and Pastor-Anglada M. Nucleoside transporters in absorptive epithelia. J. Physiol. Biochem. 58 (2002) 207-216
5. Ghose A.K., and Crippen G.M. Atomic physicochemical parameters for three-dimensional- structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions. J. Chem. Inf. Comput. Sci. 27 (1987) 21-35
6. Gray J.H., Owen R.P., and Giacomini K.M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447 (2004) 728-734
7. Hofmann A.F. Bile acids, cholesterol, gallstone calcification, and the enterohepatic circulation of bilirubin. Gastroenterology. 116 (1999) 1276-1277
8. Homma M., Jayewardene A.L., Gambertoglio J., and Aweeka F. High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes. Antimicrob. Agents Chemother. 43 (1999) 2716-2719
9. Honda M., Itoh H., Suzuki T., and Hashimoto Y. Population pharmacokinetics of higher-dose mizoribine in healthy male volunteers. Biol. Pharm. Bull. 29 (2006) 2460-2464
10. Hosotsubo H., Takahara S., and Taenaka N. Simplified high-performance liquid chromatographic method for determination of mizoribine in human serum. J. Chromatogr. 432 (1988) 340-345
11. Ishikawa H. Mizoribine and mycophenolate mofetil. Curr. Med. Chem. 6 (1999) 575-597
12. King A.E., Ackley M.A., Cass C.E., Young J.D., and Baldwin S.A. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol. Sci. 27 (2006) 416-425
13. Kullak-Ublick G.A., Stieger B., and Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology. 126 (2004) 322-342
14. Lu H., Chen C., and Klaassen C. Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice. Drug Metab. Dispos. 32 (2004) 1455-1461
15. Mackey J.R., Yao S.Y., Smith K.M., Karpinski E., Baldwin S.A., Cass C.E., and Young J.D. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J. Natl. Cancer Inst. 91 (1999) 1876-1881
16. Mizuno K., Tsujino M., Takada M., Hayashi M., and Atsumi K. Studies on bredinin. I. Isolation, characterization and biological properties. J. Antibiot. (Tokyo) 27 (1974) 775-782
17. Murakami T., Sasaki Y., Yamajo R., and Yata N. Effect of bile salts on the rectal absorption of sodium ampicillin in rats. Chem. Pharm. Bull. 32 (1984) 1948-1955
18. Naka K., Ikeda M., Abe K., Dansako H., and Kato N. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-α. Biochem. Biophys. Res. Commun. 330 (2005) 871-879
19. Okada M., Suzuki T., Nakashima M., Nakanishi T., and Fujioka N. The nucleotide derivatives inosine and inosinic acid inhibit intestinal absorption of mizoribine in rats. Eur. J. Pharmacol. 531 (2006) 140-144
20. Pastor-Anglada M., and Baldwin S.A. Recent advances in the molecular biology and physiology of nucleoside and nucleobase transporters. Drug Develop. Res. 52 (2001) 431-437
21. +-nucleoside purine (N1) transporter. Pharm. Res. 15 (1998) 950-952
22. Rauchwerger D.R., Firby P.S., Hedley D.W., and Moore M.J. Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Res. 60 (2000) 6075-6079
23. +-nucleoside cotransporter proteins (hCNT3 and mCNT3) Broadly selective for purine and pyrimidine nucleosides (system cib). J. Biol. Chem. 276 (2001) 2914-2927
24. Stypinski D., Obaidi M., Combs M., Weber M., Stewart A.J., and Ishikawa H. Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers. Br. J. Clin. Pharmacol. 63 (2006) 459-468
25. Takada K., Asada S., Ishikawa Y., Sonoda T., Takahara S., Nagano S., and Fukunishi T. Pharmacokinetics of bredinin in renal transplant patients. Eur. J. Clin. Pharmacol. 24 (1983) 457-461
26. Takatsuka S., Kitazawa T., Morita T., Horikiri Y., and Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur. J. Pharm. Biopharm. 62 (2006) 52-58
27. Takei S. Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Pediatr. Int. 44 (2002) 205-209
28. Tsuzuki K. Role of mizoribine in renal transplantation. Pediatr. Int. 44 (2002) 224-231
29. Yokota S. Mizoribine: mode of action and effects in clinical use. Pediatr. Int. 44 (2002) 196-198